A Study of Olverembatinib in SDH-deficient GIST.

Abroad (travel likely)RecruitingPHASE3

Conditions

GIST

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Ruihua Xu, M.D.,Ph.D.) · xurh@sysucc.org.cn · 020-87343468
    Contact: Principal Investigator (Ruihua Xu, M.D.,Ph.D.)
Study leads
  • Ruihua Xu, M.D., Ph.D.

    Study Chair

    Sun Yat-sen University